A method for processing incinerator bottom ash (IBA) comprises the steps of carbonating IBA aggregate material by CO.sub.2 sequestration and providing a stabilizing additive for mixing with the carbonated IBA aggregate material, wherein the additive comprises one or more components from group (b1) and one or more components from group (b2), wherein group (b1) consists of aluminium chloride and at least one other metal chloride, and wherein group (b2) consists of silica, zeolite and apatite. When the carbonated IBA and additive is mixed a stabilized IBA composition is formed, the stabilized IBA composition being suitable for use as a substitute for traditional aggregates in the manufacture of concrete and concrete products.

A method for processing incinerator bottom ash (IBA) comprises the steps of carbonating IBA aggregate material by CO.sub.2 sequestration and providing a stabilizing additive for mixing with the carbonated IBA aggregate material, wherein the additive comprises one or more components from group (b1) and one or more components from group (b2), wherein group (b1) consists of aluminium chloride and at least one other metal chloride, and wherein group (b2) consists of silica, zeolite and apatite. When the carbonated IBA and additive is mixed a stabilized IBA composition is formed, the stabilized IBA composition being suitable for use as a substitute for traditional aggregates in the manufacture of concrete and concrete products.

A method of manufacture of a powder comprising, or consisting essentially of, microspheres, the method comprising: providing a feed powder; and applying at least one spheroidisation flame to the powder. The powder may be suitable for use in medical and/or non-medical applications.

A method of manufacture of a powder comprising, or consisting essentially of, microspheres, the method comprising: providing a feed powder; and applying at least one spheroidisation flame to the powder. The powder may be suitable for use in medical and/or non-medical applications.

A medical use honeycomb structure having a plurality of through-holes extending in one direction, wherein an outer peripheral section of the medical use honeycomb structure has a through-hole groove formed by incomplete side walls of the through-hole, and a through-hole inlet adjacent to the through-hole groove.

The present specification provides a dental glass ionomer cement (GIC) composition comprising a zwitterionic material and a glass ionomer cement, and a method of preparing the same.

The present specification provides a dental glass ionomer cement (GIC) composition comprising a zwitterionic material and a glass ionomer cement, and a method of preparing the same.

Disclosed are a mixed shrinkage reducing agent for concrete and a preparation method thereof. The mixed shrinkage reducing agent for concrete includes the following components in parts by weight: 35-45 of alkali modified diatomite, 15-22 of magnesium oxide, 13-20 of vermiculite, 8-11 of borax, 3-9 of sodium hexametaphosphate, and 7-13 of citric acid modified starch. The mixed shrinkage reducing agent for concrete according to the present application is used as an admixture to be mixed into cement for preparing concrete.

In order to provide a hydroxyapatite that can be used without reservation in the food industry, a hydroxyapatite powder is provided composed of primary particles. The median size of the primary particles from which the powder is made is >0.10 μm and the aspect ratio of the primary particles is <5. The specific surface area of the hydroxyapatite powder is ≤10 m.sup.2/g, and the bulk density is >550 g/l. Also disclosed is a method with which such a hydroxyapatite powder can be obtained.

A medical use honeycomb structure having a plurality of through-holes extending in one direction, wherein an outer peripheral section of the medical use honeycomb structure has a through-hole groove formed by incomplete side walls of the through-hole, and a through-hole inlet adjacent to the through-hole groove.